ETRUVORT
Dead / Abandoned — Abandoned — after publication (as of 26 Jan 2024)
What this means for you
This application is over — abandoned 25 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97141902
- Mark type
- Stylized text
- Filed
- 24 Nov 2021
- Published for opposition
- 29 Nov 2022
- Abandoned
- 25 Jan 2024
- Attorney of record
- Tiffany Trunko
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, autoimmune diseases and dermatological diseases and disorders
Owner
- Arena Pharmaceuticals, Inc., New York, NY, US
- Arena Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 26 Jan 2024 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 26 Jan 2024 — ABANDONMENT - AFTER PUBLICATION
- 25 Jan 2024 — TEAS EXPRESS ABANDONMENT RECEIVED
- 18 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jan 2024 — SOU EXTENSION 2 GRANTED
- 16 Jan 2024 — SOU EXTENSION 2 FILED
- 16 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jul 2023 — SOU EXTENSION 1 GRANTED
- 10 Jul 2023 — SOU EXTENSION 1 FILED
- 10 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 26 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Apr 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Apr 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED